The Journal of Infectious Diseases
@jidjournal.bsky.social
In publication since 1904, JID is the premier global journal for original research on infectious diseases. JID is an official journal of @idsainfo.bsky.social
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
✅ Just Accepted
🔗 https://bit.ly/43k2ik7
✅ Just Accepted
🔗 https://bit.ly/43k2ik7
November 10, 2025 at 9:32 PM
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
✅ Just Accepted
🔗 https://bit.ly/43k2ik7
✅ Just Accepted
🔗 https://bit.ly/43k2ik7
Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trial
✅ Just Accepted
🔗 https://bit.ly/47Y2ic9
✅ Just Accepted
🔗 https://bit.ly/47Y2ic9
November 10, 2025 at 4:50 PM
Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trial
✅ Just Accepted
🔗 https://bit.ly/47Y2ic9
✅ Just Accepted
🔗 https://bit.ly/47Y2ic9
Pfs230 Domains 7-10 encoded by DNA vaccines induce potent complement-independent transmission-blocking antibody against Plasmodium falciparum.
✅ Just Accepted
🔗 https://bit.ly/3LuGOuD
✅ Just Accepted
🔗 https://bit.ly/3LuGOuD
November 9, 2025 at 8:53 PM
Pfs230 Domains 7-10 encoded by DNA vaccines induce potent complement-independent transmission-blocking antibody against Plasmodium falciparum.
✅ Just Accepted
🔗 https://bit.ly/3LuGOuD
✅ Just Accepted
🔗 https://bit.ly/3LuGOuD
Cabotegravir and Rilpivirine concentrations and HIV-1 RNA suppression in genital fluids and rectum in people with HIV on long-acting intramuscular Cabotegravir plus Rilpivirine antiretroviral therapy
✅ Just Accepted
🔗 https://bit.ly/3LAXS29
✅ Just Accepted
🔗 https://bit.ly/3LAXS29
November 9, 2025 at 6:24 PM
Cabotegravir and Rilpivirine concentrations and HIV-1 RNA suppression in genital fluids and rectum in people with HIV on long-acting intramuscular Cabotegravir plus Rilpivirine antiretroviral therapy
✅ Just Accepted
🔗 https://bit.ly/3LAXS29
✅ Just Accepted
🔗 https://bit.ly/3LAXS29
Alarming prevalence of gonococcal ceftriaxone resistance in Vietnam ? role of periodic presumptive antimicrobials?
✅ Just Accepted
🔗 https://bit.ly/4osBTJg
✅ Just Accepted
🔗 https://bit.ly/4osBTJg
November 8, 2025 at 9:14 PM
Alarming prevalence of gonococcal ceftriaxone resistance in Vietnam ? role of periodic presumptive antimicrobials?
✅ Just Accepted
🔗 https://bit.ly/4osBTJg
✅ Just Accepted
🔗 https://bit.ly/4osBTJg
Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
November 8, 2025 at 6:51 PM
Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
Serum markers of fibroinflammatory activity PRO-C3 and CPa9-HNE are associated with liver-related outcomes in patients with Chronic Hepatitis C
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
November 7, 2025 at 8:45 PM
Serum markers of fibroinflammatory activity PRO-C3 and CPa9-HNE are associated with liver-related outcomes in patients with Chronic Hepatitis C
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
A cytokine- and clinical-based risk stratification system, combined with dynamic response assessment, enables tailored treatment for pediatric EBV-HLH pati
bit.ly
November 7, 2025 at 7:11 PM
Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
Characteristics and anti-adhesion activity of chicken scFv antibodies against Helicobacter pylori HpaA
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
November 6, 2025 at 9:09 PM
Characteristics and anti-adhesion activity of chicken scFv antibodies against Helicobacter pylori HpaA
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
Non-invasive detection of occult yet significant liver pathology in ALT-normal chronic hepatitis B: a multicenter study
✅ Just Accepted
🔗 https://bit.ly/43CIA3l
✅ Just Accepted
🔗 https://bit.ly/43CIA3l
November 6, 2025 at 3:55 PM
Non-invasive detection of occult yet significant liver pathology in ALT-normal chronic hepatitis B: a multicenter study
✅ Just Accepted
🔗 https://bit.ly/43CIA3l
✅ Just Accepted
🔗 https://bit.ly/43CIA3l
HIV Reservoir Dynamics and Bacteriome Composition Along the Gut Axis
✅ Just Accepted
🔗 https://bit.ly/3Lqzksz
✅ Just Accepted
🔗 https://bit.ly/3Lqzksz
November 5, 2025 at 7:41 PM
HIV Reservoir Dynamics and Bacteriome Composition Along the Gut Axis
✅ Just Accepted
🔗 https://bit.ly/3Lqzksz
✅ Just Accepted
🔗 https://bit.ly/3Lqzksz
Natural History of Nipah Virus in Hamsters: Strain, Route, and Sex-Associated Variability Characterized using Large Datasets to Inform Pre-Clinical Study Design
✅ Just Accepted
🔗 https://bit.ly/4oTSLsi
✅ Just Accepted
🔗 https://bit.ly/4oTSLsi
November 5, 2025 at 4:23 PM
Natural History of Nipah Virus in Hamsters: Strain, Route, and Sex-Associated Variability Characterized using Large Datasets to Inform Pre-Clinical Study Design
✅ Just Accepted
🔗 https://bit.ly/4oTSLsi
✅ Just Accepted
🔗 https://bit.ly/4oTSLsi
Comparative Analysis of Flight Volume Effects on COVID-19 and Influenza Transmission Across Variable Control Intensities, 2019-2024
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
November 4, 2025 at 6:37 PM
Comparative Analysis of Flight Volume Effects on COVID-19 and Influenza Transmission Across Variable Control Intensities, 2019-2024
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55?Induced Respiratory Disease
✅ Just Accepted
🔗 https://bit.ly/492tSWH
✅ Just Accepted
🔗 https://bit.ly/492tSWH
November 4, 2025 at 3:49 PM
Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55?Induced Respiratory Disease
✅ Just Accepted
🔗 https://bit.ly/492tSWH
✅ Just Accepted
🔗 https://bit.ly/492tSWH
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
#IDSky
#IDSky
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 and has since spread worldwide
bit.ly
November 3, 2025 at 7:13 PM
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
#IDSky
#IDSky
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
#IDSky
#IDSky
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
The fitness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants was determined in human epithelial and continuous cells of the respiratory and gastrointestinal tracts
bit.ly
November 1, 2025 at 9:13 PM
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
#IDSky
#IDSky
Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines
#IDSky
#IDSky
Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines
Next-generation pneumococcal conjugate vaccines (PCVs) target an expanding array of serotype antigens.
bit.ly
October 31, 2025 at 9:15 PM
Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines
#IDSky
#IDSky
National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
October 30, 2025 at 3:50 PM
National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
Foreign Combatants Wounded in Ukraine colonized by Extensively Drug-Resistant organisms: A Potential Source of Global Dissemination
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42YYG74
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42YYG74
October 29, 2025 at 7:49 PM
Foreign Combatants Wounded in Ukraine colonized by Extensively Drug-Resistant organisms: A Potential Source of Global Dissemination
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42YYG74
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42YYG74
Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4odbS0F
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4odbS0F
October 29, 2025 at 4:09 PM
Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4odbS0F
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4odbS0F
Unexpected variability in laboratory and clinical assays used to quantify Cryptococcus neoformans polysaccharide.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nxezsL
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nxezsL
October 28, 2025 at 7:37 PM
Unexpected variability in laboratory and clinical assays used to quantify Cryptococcus neoformans polysaccharide.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nxezsL
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nxezsL
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
October 28, 2025 at 4:13 PM
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
Evaluating the impact of unadjusted confounding and study design on estimated pathogen-attributable diarrhea incidence among children in the MAL-ED cohort
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47sNvpB
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47sNvpB
October 27, 2025 at 6:54 PM
Evaluating the impact of unadjusted confounding and study design on estimated pathogen-attributable diarrhea incidence among children in the MAL-ED cohort
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47sNvpB
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47sNvpB
From vaccine discovery to pandemic modeling, AI offers transformative potential in ID research. JID wants your work on innovation & ethics. Proposals due Nov 2.
Learn more ⬇️
Learn more ⬇️
Joint Call for Papers: Leveraging AI Technologies for Discoveries and Solutions in Infectious Diseases
The IDSA journals are seeking papers focused on artificial intelligence (AI) and how it enhances and impacts infectious diseases. The journals are interested in
bit.ly
October 27, 2025 at 4:55 PM
From vaccine discovery to pandemic modeling, AI offers transformative potential in ID research. JID wants your work on innovation & ethics. Proposals due Nov 2.
Learn more ⬇️
Learn more ⬇️